Cargando…
Functional Defects From Endocrine Disease–Associated Mutations in HLXB9 and Its Interacting Partner, NONO
The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor HLXB9 that interacts with NONO/p54(NRB), a survival factor. Interestingly, two different homo...
Autores principales: | Kharade, Sampada S., Parekh, Vaishali I., Agarwal, Sunita K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793795/ https://www.ncbi.nlm.nih.gov/pubmed/29309627 http://dx.doi.org/10.1210/en.2017-03155 |
Ejemplares similares
-
Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders
por: Federico, Concetta, et al.
Publicado: (2019) -
HLXB9 Gene Expression, and Nuclear Location during In Vitro Neuronal Differentiation in the SK-N-BE Neuroblastoma Cell Line
por: Leotta, Claudia Giovanna, et al.
Publicado: (2014) -
Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2
por: Chen, Mingkun, et al.
Publicado: (2018) -
NONO and tumorigenesis: More than splicing
por: Feng, Peifu, et al.
Publicado: (2020) -
The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020)